1.045
전일 마감가:
$1.12
열려 있는:
$1.12
하루 거래량:
127.59K
Relative Volume:
0.16
시가총액:
$88.17M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.5871
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
-9.49%
1개월 성능:
+15.56%
6개월 성능:
-4.55%
1년 성능:
-70.43%
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STRO
Sutro Biopharma Inc
|
1.04 | 94.95M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference - The Manila Times
Sutro Biopharma, Inc. to Present Innovative Preclinical Data at World ADC Conference 2025 - Quiver Quantitative
Sutro (NASDAQ: STRO) to present preclinical data on dual-payload ADCs at World ADC - Stock Titan
Analyzing Sutro Biopharma Inc. with risk reward ratio chartsMarket Performance Summary & Long-Term Capital Growth Strategies - newser.com
Can technical indicators confirm Sutro Biopharma Inc.’s reversalInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Statistical indicators supporting Sutro Biopharma Inc.’s strengthJuly 2025 Technicals & Verified Entry Point Signals - newser.com
What candlestick patterns are forming on Sutro Biopharma Inc.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Is it too late to sell Sutro Biopharma Inc.Weekly Trend Report & Verified Technical Trade Signals - newser.com
Published on: 2025-11-02 22:36:42 - newser.com
Is Sutro Biopharma Inc. stock a safe haven assetDollar Strength & Daily Profit Focused Screening - newser.com
Is Sutro Biopharma Inc. stock a buy on dipsDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Can Sutro Biopharma Inc. (S09) stock deliver strong annual returnsWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Applying Wyckoff theory to Sutro Biopharma Inc. stockDividend Hike & Smart Money Movement Alerts - newser.com
Published on: 2025-11-01 09:13:17 - newser.com
Volatility clustering patterns for Sutro Biopharma Inc.Index Update & Long-Term Growth Plans - newser.com
Can Sutro Biopharma Inc. recover in the next quarterEarnings Beat & Stock Portfolio Risk Control - newser.com
How to monitor Sutro Biopharma Inc. with trend dashboards2025 Valuation Update & Precise Buy Zone Tips - newser.com
How buybacks impact Sutro Biopharma Inc. stock valuePortfolio Update Report & Technical Confirmation Alerts - newser.com
Can Sutro Biopharma Inc. stock sustain revenue growthMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Does Sutro Biopharma Inc. show high probability of rebound2025 Trade Ideas & Reliable Intraday Trade Alerts - newser.com
Identifying reversal signals in Sutro Biopharma Inc.Market Performance Recap & Real-Time Sentiment Analysis - newser.com
Why Sutro Biopharma Inc. stock is considered a top pick2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Published on: 2025-10-30 05:04:11 - newser.com
Insider Sell: Why Sutro Biopharma Inc. stock is recommended by analystsJobs Report & Advanced Technical Analysis Signals - fcp.pa.gov.br
Published on: 2025-10-28 05:06:01 - newser.com
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sutro Biopharma Inc 주식 (STRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chow Gregory K. | CFO |
Oct 15 '25 |
Buy |
0.81 |
19,750 |
15,998 |
19,750 |
| Chung Jane | Chief Executive Officer |
Oct 15 '25 |
Buy |
0.80 |
12,500 |
10,011 |
122,850 |
| MATSUI CONNIE | Director |
Oct 15 '25 |
Buy |
0.80 |
50,000 |
39,950 |
50,000 |
| Pauling David | Chief Admin. Ofcr. & GC |
Oct 15 '25 |
Buy |
0.80 |
12,504 |
9,993 |
71,737 |
| Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER |
Sep 18 '25 |
Option Exercise |
0.00 |
37,500 |
0 |
68,249 |
| Leyman Barbara | Chief Business Officer |
Jul 08 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
25,000 |
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
자본화:
|
볼륨(24시간):